Canada · Health Canada Drug Product Database

HOA 2

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
68352
DIN
02244384
Form
Capsule
Company as listed by source
MORINDA CANADA
Source status
Cancelled Post Market (2007-04-09)
Source last updated
2025-03-22

Source-listed ingredients

  • VITAMIN B1 (VITAMIN B1) — 6.25 MG
  • VITAMIN B2 (VITAMIN B2) — 12.5 MG
  • NICOTINAMIDE — 6.25 MG
  • NICOTINIC ACID — 6.25 MG
  • VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE, PYRIDOXAL-5-PHOSPHATE) — 11.5 MG
  • FOLIC ACID — 0.2 MG
  • VITAMIN B12 (VITAMIN B12) — 12.5 MCG
  • ASCORBIC ACID (ASCORBIC ACID) — 60 MG
  • VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) — 40 UNIT
  • CHROMIUM (CHROMIUM HVP CHELATE) — 35 MCG
  • COPPER (COPPER HVP CHELATE, COPPER GLUCONATE) — 0.6 MG
  • MAGNESIUM (MAGNESIUM OXIDE, MAGNESIUM HVP CHELATE) — 30.5 MG
  • MANGANESE (MANGANESE GLUCONATE, MANGANESE CITRATE, MANGANESE HVP CHELATE) — 0.115 MG
  • MOLYBDENUM (SODIUM MOLYBDATE) — 6.5 MCG
  • POTASSIUM (POTASSIUM CHLORIDE) — 6.25 MG
  • SELENIUM (SELENIUM HVP CHELATE) — 15.65 MCG
  • VANADIUM (VANADIUM HVP CHELATE) — 1.5 MCG
  • ZINC (ZINC HVP CHELATE, ZINC GLUCONATE) — 1.95 MG

These values do not establish equivalence or a dose recommendation.

Packages

  • 60

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →